Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2014 | 1 |
2015 | 1 |
2016 | 1 |
2020 | 1 |
2021 | 1 |
2023 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Proceedings of the 3rd IPLeiria's International Health Congress : Leiria, Portugal. 6-7 May 2016.
BMC Health Serv Res. 2016 Jul 6;16 Suppl 3(Suppl 3):200. doi: 10.1186/s12913-016-1423-5.
BMC Health Serv Res. 2016.
PMID: 27409075
Free PMC article.
Caballero, Fatima M. Monago, Jose T. Guerrero, Rocio M. Monago, Africa P. Trigo, Milagros L. ...Gomez, M Jose L. Fernandez, Laura A. Marquez, Ana L. Moreno, M Jesus Tena Huertas, Francisco B. ...
Caballero, Fatima M. Monago, Jose T. Guerrero, Rocio M. Monago, Africa P. Trigo, Milagros L. ...Gomez, M Jose L. Fernan …
Comparative Analysis of Putative Virulence-Associated Factors of Microsporum canis Isolates from Human and Animal Patients.
Ramos MLM, Coelho RA, Brito-Santos F, Guimarães D, Premazzi M, Zancopé-Oliveira RM, Pereira SA, Gremião IDF, Orofino-Costa R, Figueiredo-Carvalho MHG, Almeida-Paes R.
Ramos MLM, et al.
Mycopathologia. 2020 Aug;185(4):665-673. doi: 10.1007/s11046-020-00470-9. Epub 2020 Jul 8.
Mycopathologia. 2020.
PMID: 32643011
The aim of this study is to compare the expression of enzymes that may be associated with virulence, and thermotolerance of M. canis strains isolated from dogs, cats, and humans. The in vitro expression of the enzymes keratinase, catalase, urease, hemolysin, and aspartic p …
The aim of this study is to compare the expression of enzymes that may be associated with virulence, and thermotolerance of M. canis …
Item in Clipboard
Resuscitation fluid practices in Brazilian intensive care units: a secondary analysis of Fluid-TRIPS.
Freitas FGR, Hammond N, Li Y, Azevedo LCP, Cavalcanti AB, Taniguchi L, Gobatto A, Japiassú AM, Bafi AT, Mazza BF, Noritomi DT, Dal-Pizzol F, Bozza F, Salluh JIF, Westphal GA, Soares M, Assunção MSC, Lisboa T, Lobo SMA, Barbosa AR, Ventura AF, Souza AF, Silva AF, Toledo A, Reis A, Cembranel A, Rea Neto A, Gut AL, Justo APP, Santos AP, Albuquerque ACD, Scazufka A, Rodrigues AB, Fernandino BB, Silva BG, Vidal BS, Pinheiro BV, Pinto BVC, Feijo CAR, Abreu Filho C, Bosso CEDCN, Moreira CEN, Ramos CHF, Tavares C, Arantes C, Grion C, Mendes CL, Kmohan C, Piras C, Castro CPP, Lins C, Beraldo D, Fontes D, Boni D, Castiglioni D, Paisani DM, Pedroso DFF, Mattos ER, Brito Sobrinho E, Troncoso EMV, Rodrigues Filho EM, Nogueira EEF, Ferreira EL, Pacheco ES, Jodar E, Ferreira ELA, Araujo FF, Trevisol FS, Amorim FF, Giannini FP, Santos FPM, Buarque F, Lima FG, Costa FAAD, Sad FCDA, Aranha FG, Ganem F, Callil F, Costa Filho FF, Dall Arto FTC, Moreno G, Friedman G, Moralez GM, Silva GAD, Costa G, Cavalcanti GS, Cavalcanti GS, Betônico GN, Betônico GN, Reis H, Araujo HBN, Hortiz Júnior HA, Guimaraes HP, Urbano H, Maia I, Santiago Filho IL, Farhat Júnior J, Alvarez JR, Passos JT, Paranhos JEDR, Marque…
See abstract for full author list ➔
Freitas FGR, et al.
Rev Bras Ter Intensiva. 2021 Apr-Jun;33(2):206-218. doi: 10.5935/0103-507X.20210028.
Rev Bras Ter Intensiva. 2021.
PMID: 34231801
Free PMC article.
Item in Clipboard
Primary results of ROSE/TRIO-12, a randomized placebo-controlled phase III trial evaluating the addition of ramucirumab to first-line docetaxel chemotherapy in metastatic breast cancer.
Mackey JR, Ramos-Vazquez M, Lipatov O, McCarthy N, Krasnozhon D, Semiglazov V, Manikhas A, Gelmon KA, Konecny GE, Webster M, Hegg R, Verma S, Gorbunova V, Abi Gerges D, Thireau F, Fung H, Simms L, Buyse M, Ibrahim A, Martin M.
Mackey JR, et al.
J Clin Oncol. 2015 Jan 10;33(2):141-8. doi: 10.1200/JCO.2014.57.1513. Epub 2014 Sep 2.
J Clin Oncol. 2015.
PMID: 25185099
Clinical Trial.
PATIENTS AND METHODS: In this double-blind, placebo-controlled, randomized, multinational phase III trial, 1,144 patients with human epidermal growth factor receptor 2 (HER2) -negative breast cancer who had not received cytotoxic chemotherapy in the advanced setting were randomly …
PATIENTS AND METHODS: In this double-blind, placebo-controlled, randomized, multinational phase III trial, 1,144 patients with human epiderm …
Item in Clipboard
Cite
Cite